Ideaya Biosciences Stock Market Value
| IDYA Stock | USD 26.54 0.25 0.93% |
| Symbol | Ideaya |
Ideaya Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ideaya Biosciences. If investors know Ideaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ideaya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.33) | Revenue Per Share 0.051 | Quarterly Revenue Growth (0.03) | Return On Assets (0.16) | Return On Equity (0.21) |
The market value of Ideaya Biosciences is measured differently than its book value, which is the value of Ideaya that is recorded on the company's balance sheet. Investors also form their own opinion of Ideaya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ideaya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ideaya Biosciences' market value can be influenced by many factors that don't directly affect Ideaya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ideaya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ideaya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ideaya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ideaya Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ideaya Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ideaya Biosciences.
| 08/28/2024 |
| 11/26/2024 |
If you would invest 0.00 in Ideaya Biosciences on August 28, 2024 and sell it all today you would earn a total of 0.00 from holding Ideaya Biosciences or generate 0.0% return on investment in Ideaya Biosciences over 90 days. Ideaya Biosciences is related to or competes with AnaptysBio, MeiraGTx Holdings, Keros Therapeutics, Ventyx Biosciences, Protagonist Therapeutics, Verona Pharma, and Syndax Pharmaceuticals. IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery an... More
Ideaya Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ideaya Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ideaya Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 15.21 | |||
| Value At Risk | (5.09) | |||
| Potential Upside | 4.15 |
Ideaya Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ideaya Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ideaya Biosciences' standard deviation. In reality, there are many statistical measures that can use Ideaya Biosciences historical prices to predict the future Ideaya Biosciences' volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.71) | |||
| Total Risk Alpha | (0.97) | |||
| Treynor Ratio | (0.31) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ideaya Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ideaya Biosciences Backtested Returns
Ideaya Biosciences holds Efficiency (Sharpe) Ratio of -0.2, which attests that the entity had a -0.2% return per unit of risk over the last 3 months. Ideaya Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Ideaya Biosciences' Standard Deviation of 2.91, risk adjusted performance of (0.12), and Market Risk Adjusted Performance of (0.30) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.65, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ideaya Biosciences will likely underperform. At this point, Ideaya Biosciences has a negative expected return of -0.59%. Please make sure to check out Ideaya Biosciences' potential upside, and the relationship between the jensen alpha and daily balance of power , to decide if Ideaya Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.53 |
Modest predictability
Ideaya Biosciences has modest predictability. Overlapping area represents the amount of predictability between Ideaya Biosciences time series from 28th of August 2024 to 12th of October 2024 and 12th of October 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ideaya Biosciences price movement. The serial correlation of 0.53 indicates that about 53.0% of current Ideaya Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.53 | |
| Spearman Rank Test | 0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 3.15 |
Ideaya Biosciences lagged returns against current returns
Autocorrelation, which is Ideaya Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ideaya Biosciences' stock expected returns. We can calculate the autocorrelation of Ideaya Biosciences returns to help us make a trade decision. For example, suppose you find that Ideaya Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ideaya Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ideaya Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ideaya Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ideaya Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Ideaya Biosciences Lagged Returns
When evaluating Ideaya Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ideaya Biosciences stock have on its future price. Ideaya Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ideaya Biosciences autocorrelation shows the relationship between Ideaya Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Ideaya Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ideaya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ideaya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ideaya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ideaya Biosciences Stock:Check out Ideaya Biosciences Correlation, Ideaya Biosciences Volatility and Ideaya Biosciences Alpha and Beta module to complement your research on Ideaya Biosciences. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Ideaya Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.